TMO Today - Aug 13: Mixed Signals from Investors
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
TMO Today - Aug 13: Mixed Signals from Investors
-
ナレーター：
-
著者：
So, what went down? Honestly, it was a pretty quiet day overall. The trading volume was right on average, so not much frenzy happening. It seems investors were a bit split on their feelings about TMO. Some folks decided to cut back on their shares, like Y Intercept and Howland Capital, while others, like Magellan Asset Management, jumped in and added more to their positions. Kind of a mixed bag, you know?
Now, why the mixed signals? Well, there’s buzz around Thermo Fisher’s recent Q2 earnings where they beat estimates by a whopping $300 million. That’s a big win! But then you’ve got the sale of their microbiology unit to Astorg, which is a major shift for the company. Some investors are probably feeling a little uncertain about how that’ll play out. So, it’s like one step forward, one step back.
Also, there’s chatter about their stock position changes. Some are scaling back, and others are upping their game. It's interesting to see how different investors are reading the tea leaves on this one.
Looking ahead, Thermo Fisher recently closed that sale of the microbiology unit, which is a big deal. It could mean a whole new direction for them, and investors are definitely keeping an eye on what that means for the future.
So, that’s the scoop for today! Thermo Fisher is navigating some ups and downs, and it’s clear folks are weighing their options. Remember, I'm just sharing info and having a good time talking stocks, so take this as entertainment and not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません